Lilly launches Mounjaro KwikPen in India

Mumbai, August 14, 2025 — Eli Lilly and Company (India) has rolled out the Mounjaro (tirzepatide) KwikPen across the country, expanding treatment choices for people with type-2 diabetes and those…

Biocon Bets Big on Insulin, Eyes GLP-1 Drugs for Future Growth

Bengaluru – Biocon Biologics, the biopharmaceutical arm of Biocon Ltd, is strengthening its foothold in the global insulin market while making a decisive move into the booming GLP-1 drug segment.…

Lupin Ramps Up Strategy to Counter U.S. Tariff Threat, Posts 52% Profit Surge

Mumbai, August 7, 2025 — Indian pharmaceutical giant Lupin is drawing up a multi-pronged strategy to navigate the looming threat of U.S. tariffs, while celebrating a robust 52% year-on-year surge…

HC-ordered expert panel for weight loss drug may be set up by mid-July

The Central Drugs Standard Control Organization (CDSCO) is likely to begin work on forming a court-ordered expert panel to study the unregulated use of weight loss drugs by mid-July, according…

Dr Reddy’s gears up for weight loss drug study

Dr Reddy’s Laboratories has got a go-head from the Subject Expert Committee (SEC) under India’s drug regulatory authority to conduct a bioequivalence study required to establish the safety and efficacy of the blockbuster weight…